Immediate Impact

75 standout
Sub-graph 1 of 23

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
1 intermediate paper

Works of Mitsuaki Sato being referenced

Usefulness of Cell‐Free Human Telomerase Reverse Transcriptase Mutant DNA Quantification in Blood for Predicting Hepatocellular Carcinoma Treatment Efficacy
2021
Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection†
2010

Author Peers

Author Last Decade Papers Cites
Mitsuaki Sato 454 424 49 34 557
Fumitake Amemiya 385 330 58 34 533
S. Hadziyannis 442 400 58 26 623
Hsing‐Tao Kuo 466 426 23 50 609
Yoshihiko Tachi 420 378 48 30 535
Li‐Ying Liao 505 492 31 30 615
Maria Stella De Mitri 498 489 69 23 634
M.T. Tartaglione 451 432 39 19 603
M. Colombo 480 406 34 35 576
Shozo Miyake 427 346 46 37 627
Gilda Tonziello 434 455 51 25 618

All Works

Loading papers...

Rankless by CCL
2026